- India rejected a patent application for a shorter drug-resistant tuberculosis (TB) treatment regimen, emphasizing public health over evergreening. - The rejection reinforces India's strict stance on Section 3(d) of the Indian Patents Act, which prevents the patenting of mere new forms of known substances unless they show significant enhancement in efficacy. - This decision helps ensure affordable generic access to life-saving drugs, particularly for critical public health challenges like drug-resistant TB. - **Indian Patents Act (Section 3d):** A provision in India's Patents Act that prevents evergreening by disallowing patents on new forms of known substances unless they show a significant enhancement in therapeutic efficacy. - **Indian Patent Office:** The administrative body under the Ministry of Commerce and Industry responsible for granting or rejecting patent applications in India. **Introduction** The article explains India's rejection of a patent application for a shorter drug-resistant tuberculosis (TB) treatment, highlighting the application of Section 3(d) of the Indian Patents Act. It underscores the balance between intellectual property rights and public health objectives, ensuring affordable access to essential medicines. **Core Issue and Detailed Points** - India rejected a patent application for a shorter drug-resistant tuberculosis (TB) treatment regimen, emphasizing public health over evergreening. - The rejection reinforces India's strict stance on Section 3(d) of the Indian Patents Act, which prevents the patenting of mere new forms of known substances unless they show significant enhancement in efficacy. - This decision helps ensure affordable generic access to life-saving drugs, particularly for critical public health challenges like drug-resistant TB. **Key Statutory Bodies, Acts & Concepts** - **Indian Patents Act (Section 3d):** A provision in India's Patents Act that prevents evergreening by disallowing patents on new forms of known substances unless they show a significant enhancement in therapeutic efficacy. - **Indian Patent Office:** The administrative body under the Ministry of Commerce and Industry responsible for granting or rejecting patent applications in India.